These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 2151068)

  • 1. Comparative pharmacokinetics of glycopeptide antibiotics, and the influence of teicoplanin on granulocyte function.
    Lode H; Boeckh M; Höffken G; Kühn M; Gaffal H; Borner K; Koeppe P
    Scand J Infect Dis Suppl; 1990; 72():9-13. PubMed ID: 2151068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Release of vancomycin and teicoplanin from a plasticized and resorbable gelatin sponge: in vitro investigation of a new antibiotic delivery system with glycopeptides.
    Drognitz O; Thorn D; Krüger T; Gatermann SG; Iven H; Bruch HP; Muhl E
    Infection; 2006 Feb; 34(1):29-34. PubMed ID: 16501900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Glycopeptide antibiotics: eremomycin, vancomycin, and teicoplanin. Comparison of several parameters of pharmacokinetics and antimicrobial activity].
    Filippos'iants ST; Malkova IV; Gol'dberg LE
    Antibiot Khimioter; 1989 Jul; 34(7):523-6. PubMed ID: 2530944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Teicoplanin: an investigational glycopeptide antibiotic.
    Pryka RD; Rodvold KA; Rotschafer JC
    Clin Pharm; 1988 Sep; 7(9):647-58. PubMed ID: 2977108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum and bone concentrations of teicoplanin and vancomycin: study in an animal model.
    Drago L; De Vecchi E; Fassina MC; Gismondo MR
    Drugs Exp Clin Res; 1998; 24(4):185-90. PubMed ID: 10051964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetics and tissue penetration of teicoplanin.
    Novelli A; Mazzei T; Reali EF; Mini E; Periti P
    Int J Clin Pharmacol Res; 1989; 9(3):233-7. PubMed ID: 2526102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Teicoplanin: a new glycopeptide antibiotic complex.
    Babul N; Pasko M
    Drug Intell Clin Pharm; 1988 Mar; 22(3):218-26. PubMed ID: 2966729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of teicoplanin during cardiopulmonary bypass surgery.
    Mini E; Mazzei T; Reali EF; Novelli A; Periti P
    Int J Clin Pharmacol Res; 1989; 9(4):287-92. PubMed ID: 2528510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of a modified bioassay for monitoring serum teicoplanin and vancomycin in febrile neutropenic patients.
    Kureishi A; Jewesson PJ; Bartlett KH; Cole CD; Chow AW
    Antimicrob Agents Chemother; 1990 Sep; 34(9):1642-7. PubMed ID: 2149492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of resistant gram-positive infection: value of glycopeptide antibiotics vancomycin and teicoplanin].
    Waldvogel F
    Schweiz Med Wochenschr; 1993 Dec; 123(50):2353-6. PubMed ID: 8272810
    [No Abstract]   [Full Text] [Related]  

  • 11. Elimination of glycopeptide antibiotics by cytokine hemoadsorption in patients with septic shock: A study of three cases.
    Dimski T; Brandenburger T; MacKenzie C; Kindgen-Milles D
    Int J Artif Organs; 2020 Dec; 43(12):753-757. PubMed ID: 32342769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Teicoplanin in patients with chronic renal failure on dialysis: microbiological and pharmacokinetic aspects.
    Neville LO; Baillod R; Grady D; Brumfitt W; Hamilton-Miller JM
    Int J Clin Pharmacol Res; 1987; 7(6):485-90. PubMed ID: 2964417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of the possible interactions between human platelets and the antibiotic MDL-507 (teicoplanin).
    Porta M; Ricchetti I
    Int J Clin Pharmacol Ther Toxicol; 1986 Dec; 24(12):661-4. PubMed ID: 2950065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Origin, structure, and activity in vitro and in vivo of dalbavancin.
    Malabarba A; Goldstein BP
    J Antimicrob Chemother; 2005 Mar; 55 Suppl 2():ii15-20. PubMed ID: 15750032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the glycopeptide framework in the antibacterial activity of hydrophobic derivatives of glycopeptide antibiotics.
    Printsevskaya SS; Pavlov AY; Olsufyeva EN; Mirchink EP; Preobrazhenskaya MN
    J Med Chem; 2003 Mar; 46(7):1204-9. PubMed ID: 12646030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antistaphylococcal activity of teicoplanin in Riyadh, Saudi Arabia.
    Shibl AM; Ishag AH; Durgham SM
    APMIS Suppl; 1988; 3():68-70. PubMed ID: 2972301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the in vitro antibacterial activity of teicoplanin and vancomycin against gram-positive cocci.
    Ravizzola G; Pirali F; Foresti I; Turano A
    Drugs Exp Clin Res; 1987; 13(4):225-9. PubMed ID: 2957187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Glycopeptides and the newborn infant's kidney].
    Fanos V; Benini D; Vinco S; Pizzini C; Khoory BJ
    Pediatr Med Chir; 1997; 19(4):259-62. PubMed ID: 9508651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of glycopeptide antibiotics on human phagocyte activity].
    Fietta A; Sacchi F; Bersani C; De Rose V; Grassi F; Gialdroni Grassi G
    G Ital Chemioter; 1982; 29(1):11-4. PubMed ID: 6224719
    [No Abstract]   [Full Text] [Related]  

  • 20. [Activity of vancomycin and teicoplanin against clinical isolates of Staphylococcus aureus in the period 1994-1999].
    Nashev D; Toshkova K; Gavrilova V
    Vutr Boles; 2000; 32(2):35-40. PubMed ID: 11227664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.